Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria Abdelhadi RebbaaPauline M. ChouBernard L. Mirkin Original Article Pages: 423 - 428
The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin Frances M. BoyleCecilie BeatsonJohn B. Kurek Original Article Pages: 429 - 434
Stereospecific antitumor activity of radicicol oxime derivatives Shiro SogaSreenath V. SharmaShiro Akinaga Original Article Pages: 435 - 445
Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer Mikio OkaMinoru FukudaShigeru Kohno Original Article Pages: 446 - 450
8-Cl-adenosine is an active metabolite of 8-Cl-cAMP responsible for its in vitro antiproliferative effects on CHO mutants hypersensitive to cytostatic drugs Susan K. RobbinsSusan HoulbrookAdrian L. Harris Original Article Pages: 451 - 458
A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion Charlotte van Kesteren R. Mathôt J. Beijnen Original Article Pages: 459 - 466
Phase I clinical and pharmacokinetic trial of irofulven James P. ThomasRhoda ArzoomanianHoward Bailey Original Article Pages: 467 - 472
Antiangiogenic and antitumor effects of a protein kinase Cβ inhibitor in murine Lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts Beverly A. TeicherKrishna MenonMargaret M. Faul Original Article Pages: 473 - 480
Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer Mitsuo SatoMasahiko AndoYoshinori Hasegawa Original Article Pages: 481 - 487
Gemcitabine activity in cervical cancer cell lines Patricia HernándezPrimitivo OliveraJorge Meléndez-Zajgla Original Article Pages: 488 - 492
Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics David Z. ChangThomas OlenckiRonald Bukowski Original Article Pages: 493 - 498
A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients Hiroshi SakaiShuichi YonedaNagahiro Saijo Clinical Trial Report Pages: 499 - 503
